Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  BioMarin Pharmaceutical Inc.    BMRN

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo BioMarin Pharmaceutical In
Discovers, develops and commercializes innovative pharmaceuticals for serious diseases & medical conditions

BioMarin Pharmaceutical, Inc. engages in the biopharmaceutical development and commercialization of innovative pharmaceuticals for serious diseases and medical conditions.

Its company's products include Naglazyme, Kuvan, Aldurazyme, Firdapse and VIMIZIM.

The company was founded on March 21, 1997 and is headquartered in Novato, CA.

Number of employees : 2 158 persons.
Sales per Businesses
20142015Delta
USD (in Million)%USD (in Million)%
Biopharmaceutical Development and Commercialization751.04100.1%889.90102% +18.49%
Sales per Regions
20142015Delta
USD (in Million)%USD (in Million)%
United States380.0450.7%444.0850.9% +16.85%
Europe139.9418.7%178.7520.5% +27.73%
Latin America118.5615.8%142.3116.3% +20.03%
Rest of World112.4915%124.7714.3% +10.91%
Managers
NameAgeSinceTitle
Jean-Jacques Bienaimé632005Chairman & Chief Executive Officer
Daniel K. Spiegelman, MBA582012Chief Financial Officer & Executive Vice President
Henry J. Fuchs, MD592009Chief Medical Officer & Executive Vice President
Eduardo E. Von Pervieux, MBA-2008Chief Information Officer & Vice President
Elaine J. Heron PhD, MBA692002Independent Non-Executive Director
Michael G. Grey642005Independent Non-Executive Director
Richard A. Meier572006Lead Independent Non-Executive Director
V. Bryan Lawlis Jr., PhD652007Independent Non-Executive Director
Alan J. Lewis, PhD712005Independent Non-Executive Director
Dennis Joseph Slamon MD, PhD682014Independent Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 171,987,437 171,099,273 99.5% 0 0.0% 99.5%
Shareholders
NameEquities%
Capital Research & Management Co. (Global Investors) 20,216,215 11.8%
The Vanguard Group, Inc. 12,230,286 7.11%
Sands Capital Management LLC 10,221,282 5.94%
Jennison Associates LLC 9,702,200 5.64%
Fidelity Management & Research Co. 8,712,072 5.07%
BlackRock Fund Advisors 8,180,731 4.76%
PRIMECAP Management Co. 7,108,129 4.13%
Baker Bros. Advisors LP 4,806,483 2.79%
SSgA Funds Management, Inc. 3,635,047 2.11%
Temasek Holdings Pte Ltd. (Investment Management) 3,472,712 2.02%
Holdings
NameEquities%Valuation
Catalyst Pharmaceuticals Inc (CPRX) 6,666,6678.03%7,000,000 USD
Sector
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Biopharmaceuticals
Advertisement
Sector Biopharmaceuticals
1st jan.Capitalization (M$)
BIOMARIN PHARMACEUTICA..4.93%14 949
BIOGEN INC0.41%61 954
CSL LIMITED0.67%34 476
ALEXION PHARMACEUTICAL..11.92%30 663
GRIFOLS SA1.75%13 046
CHONGQING ZHIFEI BIOLO..--.--%3 359
3SBIO INC-4.21%2 382
ABCAM PLC4.95%1 986
JIANGXI BOYA BIO-PHARM..--.--%1 952
PROMETIC LIFE SCIENCES..-5.26%1 027
HUGEL INC--.--%944
ANIKA THERAPEUTICS INC2.19%732
PHARMA MAR SA4.80%672
BIOTEST AG6.60%658
ARGOS THERAPEUTICS INC10.20%223
VIVUS, INC.4.35%126
MEDIWOUND LTD15.74%116
VERICEL CORP-1.67%94
CARDIOME PHARMA CORP-5.30%92
ALIMERA SCIENCES INC17.59%82
CO DON AG24.09%69
Sector Biopharmaceuticals
BioMarin Pharmaceutical In : Connections
770 street Lindaro
CA 94901 San Rafael, California
États-Unis (les)

Phone : +1 415 506 6700
Fax : +1 415 382 7889
Internet : http://www.bmrn.com
Markets and indexes
- NASDAQ All Markets
- Nasdaq Global Select Market
- Nasdaq 100 /
Stock Exchange Codes
- ISIN Code :  US09061G1013
- Bloomberg Code :  
- Reuters Code :  BMRN.O
- Datastream Code :  
© 2017 People , Fundamentals and Ownership    © 2017 Cofisem